Company: KROS
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-037982
Chunk: 88

Company: Keros Therapeutics, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 88
---
 
 ​ | (c) Number of SecuritiesRemaining Available forIssuance Under EquityCompensation Plans(Excluding SecuritiesReflected in Column (a)) 
 ​                                                                                                                                   | ​ |            ​ | ​ | ​ 
 ​ |
|:-----------------------------------------------------------|:--|:--|:------------------------------------------------------------------------------------------|:--|----------:|:--|:--|:--|:----------------------------------------------------------------------------|:--|------:|:--|:--|:--|:------------------------------------------------------------------------------------------------------------------------------------|:--|-------------:|:--|:--|
| 2017 Stock Incentive Plan, as amended                      | ​ | ​ | ​                                                                                         | ​ |   477,752 | ​ | ​ | ​ | ​                                                                           | $ |  0.35 | ​ | ​ | ​ | ​                                                                                                                                   | ​ |         —(1) | ​ | ​ |
| 2020 Equity Incentive Plan                                 | ​ | ​ | ​                                                                                         | ​ | 4,907,008 | ​ | ​ | ​ | ​                                                                           | $ | 46.26 | ​ | ​ | ​ | ​                                                                                                                                   | ​ |   861,617(2) | ​ | ​ |
| 2020 Employee Stock Purchase Plan                          | ​ | ​ | ​                                                                                         | ​ |         — | ​ | ​ | ​ | ​                                                                           | ​ |     — | ​ | ​ | ​ | ​                                                                                                                                   | ​ | 1,247,861(3) | ​ | ​ |
| Equity compensation plans not approved by security holders | ​ | ​ | ​                                                                                         | ​ |         — | ​ | ​ | ​ | ​                                                                           | ​ |     — | ​ | ​ | ​ | ​                                                                                                                                   | ​ |            — | ​ | ​ |
| Total                                                      | ​ | ​ | ​                                                                                         | ​ | 5,384,760 | ​ | ​ | ​ | ​                                                                           | ​ |     ​ | ​ | ​ | ​ | ​                                                                                                                                   | ​ |    2,109,478 | ​ | ​ |

(1) No further grants were made under our 2017 Stock Incentive Plan, as amended, after the completion of our IPO on April 13, 2020. (2) The number of shares of common stock reserved for issuance under the 2020 Plan will automatically increase on January 1 of each year, beginning on January 1, 2021 and continuing through and including January 1